Ozan Pamir is CFO at Niagen Bioscience (NASDAQ: NAGE), where he leads financial strategy, planning, and investor relations for the global NAD+ and healthy aging leader. He brings over a decade of experience in finance and economics, previously serving as CFO at 180 Life Sciences and VP of Investment Banking specializing in life sciences M&A and IPOs. Ozan holds a degree in Economics and Finance from McGill University and is a CFA Charterholder.